Bank Of New York Mellon Corp Bioventus Inc. Transaction History

Bank Of New York Mellon Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$1.07 - $2.95 $196,016 - $540,419	183,193 New	183,193 $196 Million
Q4 2022 Feb 14, 2023	BUY	$1.81 - $8.14 $349,769 - $1.57 Million	193,243 New	193,243 $504,000
Q3 2022 Nov 14, 2022	BUY	$6.54 - $9.08 $66,047 - $91,698	10,099 Added 5.07%	209,266 $1.47 Million
Q2 2022 Aug 15, 2022	BUY	$6.82 - $13.82 $310,037 - $628,257	45,460 Added 29.58%	199,167 $1.36 Million
Q1 2022 May 11, 2022	BUY	$11.65 - $15.28 $51,050 - $66,956	4,382 Added 2.93%	153,707 $2.17 Million
Q4 2021 Feb 11, 2022	BUY	$12.37 - $16.77 $1.12 Million - $1.52 Million	90,694 Added 154.69%	149,325 $2.16 Million
Q3 2021 Nov 12, 2021	BUY	$13.7 - $17.25 $563,248 - $709,199	41,113 Added 234.69%	58,631 $830,000
Q2 2021 Aug 11, 2021	BUY	$13.75 - $18.8 $19,483 - $26,639	1,417 Added 8.8%	17,518 $308,000
Q1 2021 May 13, 2021	BUY	$11.49 - $19.21 $185,000 - $309,300	16,101 New	16,101 $246,000

142

45.8M

179K

124K

Ticker BVS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 61,664,200
Market Cap $619M
Description
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.